Using a heart-related fainting risk score in emergency care
Part of Brain & nervous system clinical trials.
This trial helps emergency departments use a simple risk score to guide care for adults who faint. It looks at whether using these recommended steps improves how syncope (fainting) is assessed and managed in the ER.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years) who comes to the emergency department within 24 hours of fainting
- Your episode fits the study’s definition of fainting (not an extended blackout or another condition like seizure)
- No obvious seizure happened, and there was no head injury right before the loss of consciousness
- You can share the necessary details about what happened (for example, not too intoxicated to give a reliable history)
- The ER workup does not find a serious non-fainting cause that requires admission for reasons other than the syncope workup
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have had repeated fainting spells and still don’t know the cause. It tests whether different types of heart monitoring (like tilt testing or an ECG/heart tracing) can better explain what’s triggering syncope and guide prevention.
This trial studies whether remote heart monitoring after an ER visit for fainting (syncope) can help identify dangerous heart problems. You may be enrolled only if your fainting episode seems medium- to high-risk and you’re being sent home from the ER.
This trial studies how well a risk score can be used by paramedics to assess people who faint (“syncope”) after calling 911. It may help emergency teams decide how urgently you need care after a fainting episode.
This study looks at whether people who come to the hospital after a fainting spell can be safely watched for 24 hours inside the hospital, instead of being admitted for a longer stay. It may help doctors decide the best way to monitor low- and intermediate-risk fainting.
This trial tests a “global” approach to assessing episodes of fainting or falling in people age 40 and older. It may help doctors find the right cause and safer next steps after an episode.
This trial studies a procedure that targets a specific heart nerve area on the right side to reduce neurally mediated fainting (syncope). You may be a candidate if your fainting is linked to heart rhythm/nerve reflexes and you meet several heart-function and heart-rhythm test criteria.
Hear when a new Syncope trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.